BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cellceutix 

100 Cumming Center, Suite 151-B
Suite A225
Beverly  Massachusetts  01915  U.S.A.
Phone: 978-236-8717 Fax: 978-921-6564


SEARCH JOBS










 Company News
Study Shows Cellceutix (CTIX) Antibiotic Active Against Drug-Resistant Superbug Klebsiella Pneumoniae 4/14/2014 10:11:54 AM    More...
Cellceutix (CTIX) Comments On Positive FDA Advisory Vote For Dalbavancin And Tedizolid 4/2/2014 11:03:07 AM    More...
Cellceutix (CTIX) Reports 20 Percent Enrollment Completed In Phase 2b Trial Of Brilacidin As Short-Course Therapy For ABSSSI 3/31/2014 8:56:32 AM    More...
Cellceutix (CTIX) Initiates Clinical Trial Of Prurisol As New Treatment For Psoriasis 3/25/2014 9:18:50 AM    More...
Cellceutix (CTIX) To Initiate Psoriasis Clinical Trial 3/24/2014 8:51:28 AM    More...
Seventh Cohort Underway In Cellceutix (CTIX) Clinical Trial Of Kevetrin For Solid Tumors 3/19/2014 10:04:43 AM    More...
Cellceutix (CTIX) Reports 14 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Patients Treated In Phase 2b Clinical Trial 3/10/2014 10:22:28 AM    More...
Cellceutix (CTIX) Expands To Gram-Negative Bacterial Infections 3/6/2014 9:44:29 AM    More...
Cellceutix (CTIX) Enrolls First Patients In Phase 2b ABSSSI Clinical Trial 2/26/2014 12:30:06 PM    More...
Cellceutix (CTIX) Selects Dr. Reddy's Laboratories Ltd. (RDY) For Formulation Of Brilacidin For Ophthalmic And Otitis Infections 2/24/2014 9:14:34 AM    More...
12345678910...